spacer
home > ict > winter 2019 > animal models to study infectious pathogens
PUBLICATIONS
International Clinical Trials

Animal Models to Study Infectious Pathogens

Until recently, several issues prevented the use of cotton rats (Sigmodon hispidus) as an experimental model on a widespread level. They lacked inbreeding, they were not readily commercially available, and reagents specific to this species had yet to be developed. Additionally, cotton rats are notoriously hard models to work with. Although cotton rats are not normally aggressive, they dislike being handled, can move very rapidly, and jump well. Significant advances have now been made to alleviate these issues. A variety of immunological methods have been established for the cotton rat so that immunological responses after infection or vaccination can be evaluated. Also, a wide variety of chemokine and cytokine genes have been cloned and enzyme-linked immunosorbent assay and other antibody-based systems are readily available. Some strategies can overcome the challenges of working with cotton rats, and their necessity to vaccine development ultimately makes them more than worth the trouble.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Carmen Sweeney PhD is the Scientific Director of in vivo/ex vivo testing services at Charles River’s site, Ballina, Ireland. Carmen has over 20 years’ experience in the industry, having held a number of positions at Charles River, from Study Director, Manager of Methods Development, to her current role. Carmen received her PhD in biological and biomedical sciences and toxicology MSc from the University of Ulster, UK.
spacer
Carmen Sweeney PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Regulatory bottlenecks mean EU clinicians and patients could lose access to medical devices under new rules

European clinicians and their patients could lose access to vital medical devices, including in-vitro diagnostics, due to a lack of agencies able to certify products in time to comply with strict new regulations.
More info >>

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement